Agios Pharma (AGIO) Tops Q3 EPS by 6c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.64), $0.06 better than the analyst estimate of ($1.70). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $7.64 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy